to page content
to site navigation
The Foundation's primary site.
Global news, events, and resources.
The national learning program for entrepreneurs.
A new approach to developing the next generation of high-growth firms.
Access to university research and innovation.
The Kauffman Foundation's charter school serving Kansas City.
Encouraging the aspirations of young people.
The platform for business plan competitions.
College preparation and access for urban youth in Kansas City.
A guide to Kauffman Foundation and partner resources, for aspiring entrepreneurs.
News and announcements from the Foundation.
From our vice president of Entrepreneurship.
From our vice president of Advancing Innovation.
News from Global Entrepreneurship Week
News about this education program for entrepreneurs.
Tweets for the eMed Community at Entrepreneurship.org
News from the Kauffman Labs program.
From our business plan competition service.
Contribute to the community seeking to improve entrepreneurship and innovation measurement.
A look at entrepreneurship from the Kauffman Foundation's Thom Ruhe.
Tracks research and policies that are accelerating economic growth and changing the world.
Brings to light various policies and initiatives to advance innovation and drive economic growth.
A selection of our videos
Take our video and audio with you.
Explore many of our publications.
Join the discussion on our LinkedIn site.
Join us on Google's social service.
The Resource Center has all the info you'll need From content to user feedback, the resource center has the information you need for every level of the entrepreneurial process.
Recognizing that cash is king, this entrepreneur gives an overview of why your active involvement in managing cash on a daily basis is critical and how it will allow you to become a more informed leader and develop a keen operational awareness of your company's finances and its capabilities.
Teresa Briggs currently serves as a Managing Partner at Deloitte's Silicon Valley office. Over the past two years, Briggs has worked to double the firm's staff to at least 1,300. She joined the firm when only seven percent of the partners were women. She arrived at Deloitte & Touche as one of the youngest partners in the company. Rising quickly, she moved to Deloitte's New York office working to redesign the company's corporate strategy at a national level, which then led to her current position. On top of all her accomplishments at Deloitte, Briggs has served on the Management Board of Advisors at her alma mater, the University of Arizona, and she spent eight years serving on the board of the Boys and Girls Club of San Francisco. Teresa also recently participated in the Leadership Group's Annual CEO/Elected Official Cycle‐To‐Work Day Challenge to help curb climate change, riding from Redwood Shores to downtown San Jose and back. She was also recently named a "Woman of Distinction" in the San Jose / Silicon Valley Business Journal, and she has been added to the Business Journal's "Who's Who in Silicon Valley" list. Briggs holds a Bachelor of Science from the University of Arizona.
Dr. Larry Brilliant is the Executive Director of Google.org, where he leads major initiatives aimed at reducing global poverty, improving the health of the least advantaged in the world, and working to halt the effects of the climate crisis. Larry is an M.D. and M.P.H., board-certified in preventive medicine and public health. He is a founder and director of The Seva Foundation, which works in dozens of countries around the world, primarily to eliminate preventable and curable blindness. He serves as a member of the strategic advisory committee for Kleiner Perkins (KPCB) Venture Capital and also sits on the boards of The Skoll Foundation, Health Metrics Network, Omidyar Networks Humanity United, and InSTEDD, an organization bringing technological tools to improve disaster response. In addition to his medical career, Larry co-founded The Well, a pioneering virtual community, with Stewart Brand in 1985. He also holds a telecommunications technology patent and has served as CEO of two public companies and other venture-backed start-ups. The author of two books and dozens of articles on infectious diseases, blindness, and international health policy, Larry has worked at every level of government. He was recently a "first responder" for CDC's smallpox bio-terrorism response effort, volunteered in Sri Lanka for tsunami relief, and established an interdisciplinary consultancy to prepare for possible pandemic influenza. Larry lived in India working as a United Nations medical officer for more than a decade where he played a key role in the successful World Health Organization (WHO) smallpox eradication program and has recently worked for the WHO polio eradication effort as well. He was Associate Professor of epidemiology, global health planning and economic development at the University of Michigan. Larry earned a Masters in Public Health in health planning and economic development from the Univ
Terry Bruggeman shares the tale of leading his life sciences company through the decision to obtain capital. After exploring the funding options, including VC and IPO, Bruggeman and his team decide to undertake a reverse merger.
Tom Byers is a professor at Stanford University where he focuses on high-technology entrepreneurship education. He is founder and a faculty director of the Stanford Technology Ventures Program (STVP), which serves as the entrepreneurship center for the engineering school. STVP includes the Mayfield Fellows work/study program, Educators Corner website of teaching resources, and global Roundtable on Entrepreneurship Education conferences. Tom is also a faculty director of the AEA/Stanford Executive Institute, a general management program for technology executives. Tom is co-author of the textbook called "Technology Ventures: From Idea to Enterprise" (McGraw-Hill, 2005). Tom also holds a visiting professor appointment at the London Business School and University College London. Tom currently serves as a director on the boards of Reactivity and Flywheel Ventures. In addition, he serves on advisory boards or committees of the American Society for Engineering Education's Entrepreneurship Division, Harvard Business School's California Research Center, and the National Foundation for Teaching Entrepreneurship (NFTE) for inner-city youth. Previously, Tom lectured at the Haas School of Business at the University of California, Berkeley. Tom has a range of business experience including executive vice president of Symantec Corporation and founder/president of Slate Corporation. Tom started his professional career at Accenture. For his efforts at Stanford, Tom holds an endowed chair known as the McCoy University Fellow in Undergraduate Education. Tom was given the 2005 Gores Award for excellence in teaching (the university's highest award) and the 2002 Tau Beta Pi Award for excellence in undergraduate teaching (the engineering school's highest award). He is a recipient of three recent national teaching awards: the 2005 ASEE Kauffman Award for excellence in engineering and technology entrepreneurship
Brook Byers has been a venture capital investor since 1972. He has been closely involved with more than forty new technology based ventures, over half of which have already become public companies. He formed the first Life Sciences practice group in the venture capital profession in 1984 and led KPCB to become a premier venture capital firm in the medical, healthcare, and biotechnology sectors. KPCB has invested in and helped build over 90 Life Sciences companies which are developing hundreds of products to treat major underserved medical needs representing huge markets in the nearly two trillion dollar healthcare sector. Brook was the founding President and then Chairman of four biotechnology companies which were incubated in KPCB's offices and went on to become public companies with an aggregate market value over $8 Billion. He is currently on the Board of Directors of eight companies, most recently joining CardioDX, Genomic Health Incorporated, Five Prime Therapeutics, Nanofluidics and XDx, Inc.. He was formerly a Director of Idec Pharmaceuticals (Chairman), Athena Neurosciences (Chairman), Signal Pharmaceuticals, Arris Pharmaceuticals, Pharmacopeia, Ligand Pharmaceuticals (Chairman), Hybritech (Chairman), Genprobe, Nanogen, and others. These companies have pioneered the medical uses of molecular biology, monoclonal antibodies, molecular diagnostics and genomics. Brook was President and a Director of the Western Association of Venture Capitalists and is a contributing author to the book "Guide to Venture Capital". He is currently a Board member of the University of California at San Francisco Medical Foundation, the California Healthcare Institute, the New Schools Foundation, Stanford's Bio-X Advisory Council, the Stanford Eye Council and TechNet. He is Co-Chair of the current five year, $1.4 billion, UCSF Capital Campaign. He was formerly a Director of the Entrepreneurs Foundation, t
Barbara Carey, an entrepreneur and product innovator, tells her story about bootstrapping her company with $800 and how she secured her first order and first manufacturer. Carey's golden rule: get your product or service order first before making any business commitments.
An effective method of managing your company's cash flow is using accounts payable (A/P). The author outlines steps to prioritize A/P and recommends you treat vendors as a critical part of the success of your company.
Ohio voters to decide if $700M bond issue expands investment in high-tech economy.
Self-healing metal that pops back into shape after it's damaged. Machines that give surgeons full-color, 3D images of a patient's insides. Sensors that warn police or soldiers of explosives miles away. This is the promise of a proposed $700 million statewide investment program that aims to turn sci-fi dreams into Ohio's business future. But does the promise hold up?
Running your own business on your own terms means freedom in your schedule and approach. It can also mean slim funding. This Co-founder of The Baby Einstein Company was seeking to avoid entanglement with venture capitalists and found that doing business on a cash-only basis was the answer.
Want to get connected? Sign up to receive regular news, polls and updates from The Kauffman Foundation.
